SIRTLab Corporation is focused on the treatment of severe Non-Alcoholic Steatohepatitis (NAXH), other Severe Liver Diseases and Longevity based on Sirtuin 6 (SIRT6) modulation.
Chairperson of the Board
BiVictriX Therapeutics Ltd
Jan 2022 - Current(4 years 6 months)
Board Member
Adicet Bio Inc
Jan 2022 - Aug 2024(2 years 8 months)
Cofounder
Karyopharm Therapeutics Inc
May 2021 - Current(5 years 2 months)
Senior Clinical Advisor
Karyopharm Therapeutics Inc
May 2021 - May 2022(1 year 1 month)
Board Member
Kezar Life Sciences
Jan 2017 - Current(9 years 6 months)
CEO
Karyopharm Therapeutics Inc
Jan 2011 - May 2021(10 years 5 months)
Discovery, development, approval and commercialization of XPOVIO® (NEXPOVIO®) for multiple myeloma and lymphoma. Additional novel drugs targeting the nuclear pore complex for cancer, inflammation, viral diseases, and other disorders of proliferation.
Lead Director, Board Member
Verastem Oncology
Jan 2010 - Dec 2025(16 years)
Chief Medical Officer
Onyx Pharmaceuticals Inc an Amgen subsidiary
Nov 2009 - Dec 2010(1 year 2 months)
Operating Partner
Bessemer Venture Partners
Jan 2009 - Dec 2010(2 years)
P
Chief Medical Officer
Proteolix Pharmaceuticals Inc
Dec 2008 - Oct 2009(11 months)
E
Chief Executive Officer
EPIX Pharmaceuticals
Aug 2006 - Aug 2008(2 years 1 month)
Z
Board Member
Zalicus Inc
May 2006 - Jul 2014(8 years 3 months)
P
Chief Executive Officer
Predix Pharmaceuticals Inc
Sep 2002 - Aug 2006(4 years)
Rheumatology Fellowship / Internal Medicine Practice
Massachusetts General Hospital
Jul 1994 - Sep 1995(1 year 3 months)
Internal Medicine Practice
Rheumatology Fellowship
B
Internal Medicine Residency
BETH ISRAEL HOSPITAL
Jul 1992 - Jun 1994(2 years)
Internal Medicine Residency
Harvard Teaching Hospital